Gain Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q2 2022 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Gain Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2022 to Q1 2024.
Gain Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $2.02M, a 82.9% decline year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$2.02M	-$9.81M	-82.9%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$5M	-$7.83M	-61%	Dec 31, 2023	10-Q	2024-08-08
Q3 2023	$7.96M	-$3.89M	-32.8%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$9.87M	-$66.3K	-0.67%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$11.8M			Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$12.8M			Dec 31, 2022	10-K	2024-03-26
Q3 2022	$11.9M			Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$9.94M			Jun 30, 2022	10-Q	2022-08-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.